
### [NCIT:C3750](http://purl.obolibrary.org/obo/NCIT_C3750)
**Label:** Alveolar Soft Part Sarcoma

**Subclasses:** [NCIT:C40320](http://purl.obolibrary.org/obo/NCIT_C40320) (Vulvar Alveolar Soft Part Sarcoma), [NCIT:C8092](http://purl.obolibrary.org/obo/NCIT_C8092) (Childhood Alveolar Soft Part Sarcoma), [NCIT:C7943](http://purl.obolibrary.org/obo/NCIT_C7943) (Adult Alveolar Soft Part Sarcoma), [NCIT:C8797](http://purl.obolibrary.org/obo/NCIT_C8797) (Primary Alveolar Soft Part Sarcoma), [NCIT:C8798](http://purl.obolibrary.org/obo/NCIT_C8798) (Recurrent Alveolar Soft Part Sarcoma), [NCIT:C8796](http://purl.obolibrary.org/obo/NCIT_C8796) (Metastatic Alveolar Soft Part Sarcoma), [NCIT:C40225](http://purl.obolibrary.org/obo/NCIT_C40225) (Cervical Alveolar Soft Part Sarcoma), 

**Class expressions from DL-Learner:**

- Thing 53.35%
- [NCIT:C60643](http://purl.obolibrary.org/obo/NCIT_C60643) (Adulthood Lesion) 52.94%
- [NCIT:C40558](http://purl.obolibrary.org/obo/NCIT_C40558) (Primary Lesion) 52.94%
- [NCIT:C40557](http://purl.obolibrary.org/obo/NCIT_C40557) (Metastatic Lesion) 52.94%
- [NCIT:C38155](http://purl.obolibrary.org/obo/NCIT_C38155) (Recurrent Disease) 52.94%
- [NCIT:C35460](http://purl.obolibrary.org/obo/NCIT_C35460) (Crystal Formation) 38.30%
- [NCIT:C35460](http://purl.obolibrary.org/obo/NCIT_C35460) (Crystal Formation) and (not ([NCIT:C39826](http://purl.obolibrary.org/obo/NCIT_C39826) (Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant without Heterologous Elements))) 38.30%
- [NCIT:C35460](http://purl.obolibrary.org/obo/NCIT_C35460) (Crystal Formation) and (not ([NCIT:C39825](http://purl.obolibrary.org/obo/NCIT_C39825) (Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant with Heterologous Elements))) 38.30%
- [NCIT:C35460](http://purl.obolibrary.org/obo/NCIT_C35460) (Crystal Formation) and (not ([NCIT:C39821](http://purl.obolibrary.org/obo/NCIT_C39821) (Infiltrating Bladder Lymphoepithelioma-Like Carcinoma))) 38.30%
- [NCIT:C35460](http://purl.obolibrary.org/obo/NCIT_C35460) (Crystal Formation) and (not ([NCIT:C39820](http://purl.obolibrary.org/obo/NCIT_C39820) (Infiltrating Bladder Urothelial Carcinoma, Microcystic Variant))) 38.30%
- [NCIT:C35460](http://purl.obolibrary.org/obo/NCIT_C35460) (Crystal Formation) and (not ([NCIT:C39819](http://purl.obolibrary.org/obo/NCIT_C39819) (Infiltrating Bladder Urothelial Carcinoma, Nested Variant))) 38.30%
- [NCIT:C35460](http://purl.obolibrary.org/obo/NCIT_C35460) (Crystal Formation) and (not ([NCIT:C39818](http://purl.obolibrary.org/obo/NCIT_C39818) (Infiltrating Bladder Urothelial Carcinoma with Trophoblastic Differentiation))) 38.30%
- [NCIT:C35460](http://purl.obolibrary.org/obo/NCIT_C35460) (Crystal Formation) and (not ([NCIT:C39817](http://purl.obolibrary.org/obo/NCIT_C39817) (Infiltrating Bladder Urothelial Carcinoma with Glandular Differentiation))) 38.30%
- [NCIT:C35460](http://purl.obolibrary.org/obo/NCIT_C35460) (Crystal Formation) and (not ([NCIT:C39816](http://purl.obolibrary.org/obo/NCIT_C39816) (Infiltrating Bladder Urothelial Carcinoma with Squamous Differentiation))) 38.30%
- [NCIT:C35460](http://purl.obolibrary.org/obo/NCIT_C35460) (Crystal Formation) and (not ([NCIT:C39815](http://purl.obolibrary.org/obo/NCIT_C39815) (Cellular Congenital Mesoblastic Nephroma))) 38.30%


